Landmark gene therapy for hereditary blindness closes in on FDA approval

Back in August, the FDA approved the first gene therapy for general use in the United States. That particular treatment, for cancer, was beset by controversy due to its exorbitant price tag and potential side effects. Now another gene therapy is on the cusp of approval, this time to treat a form of hereditary blindness. If given the tick by the FDA, this therapy could pave the way for a whole host of treatments for genetically-based vision problems…
Continue Reading Landmark gene therapy for hereditary blindness closes in on FDA approval

Category: Medical

Tags:

Blindness

Eye

Genetics

Vision

Related Articles:

Eye2TV adapter aims to improve the TV viewing experience for colorblind users

Microsoft app caters to the colorblind

Blindness strikes three women after iffy stem-cell treatments

Soft artificial retina might make for smoother eye implants

EnChroma glasses designed to compensate for color-blindness

O2Amps glasses designed to help read peoples’ emotions find other applications

The message will be closed after 20 s